Cargando…

Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder

Central nervous system methotrexate-associated lymphoproliferative disorder (CNS-MTX-LPD) is rare, but its spontaneous regression has been observed in some patients after withdrawal of agents. We herein report three cases of primary CNS-MTX-LPD that received oral MTX for rheumatoid arthritis. Epstei...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Hiroki, Ohno, Narumi, Abe, Takafumi, Kimoto, Kazuki, Matsuoka, Chika, Giga, Mayumi, Naito, Hiroyuki, Kono, Tomoyuki, Takasu, Miyuki, Kidani, Naoya, Yamasaki, Rie, Ichimura, Koichi, Nomura, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841117/
https://www.ncbi.nlm.nih.gov/pubmed/35598995
http://dx.doi.org/10.2169/internalmedicine.9296-21
_version_ 1784869761767702528
author Ueno, Hiroki
Ohno, Narumi
Abe, Takafumi
Kimoto, Kazuki
Matsuoka, Chika
Giga, Mayumi
Naito, Hiroyuki
Kono, Tomoyuki
Takasu, Miyuki
Kidani, Naoya
Yamasaki, Rie
Ichimura, Koichi
Nomura, Eiichi
author_facet Ueno, Hiroki
Ohno, Narumi
Abe, Takafumi
Kimoto, Kazuki
Matsuoka, Chika
Giga, Mayumi
Naito, Hiroyuki
Kono, Tomoyuki
Takasu, Miyuki
Kidani, Naoya
Yamasaki, Rie
Ichimura, Koichi
Nomura, Eiichi
author_sort Ueno, Hiroki
collection PubMed
description Central nervous system methotrexate-associated lymphoproliferative disorder (CNS-MTX-LPD) is rare, but its spontaneous regression has been observed in some patients after withdrawal of agents. We herein report three cases of primary CNS-MTX-LPD that received oral MTX for rheumatoid arthritis. Epstein-Barr virus and oligoclonal bands (OCBs) were positive, while proton magnetic resonance spectroscopy ((1)H-MRS) showed an elevated lipid peak and slightly elevated choline/N-acetylaspartate ratio in common. After MTX withdrawal, brain lesions showed spontaneous regression in all cases. Our patient's (1)H-MRS findings and OCBs may reflect a non-monoclonal lymphoproliferative histology as benign-type lesions in CNS-MTX-LPD.
format Online
Article
Text
id pubmed-9841117
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-98411172023-01-26 Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder Ueno, Hiroki Ohno, Narumi Abe, Takafumi Kimoto, Kazuki Matsuoka, Chika Giga, Mayumi Naito, Hiroyuki Kono, Tomoyuki Takasu, Miyuki Kidani, Naoya Yamasaki, Rie Ichimura, Koichi Nomura, Eiichi Intern Med Case Report Central nervous system methotrexate-associated lymphoproliferative disorder (CNS-MTX-LPD) is rare, but its spontaneous regression has been observed in some patients after withdrawal of agents. We herein report three cases of primary CNS-MTX-LPD that received oral MTX for rheumatoid arthritis. Epstein-Barr virus and oligoclonal bands (OCBs) were positive, while proton magnetic resonance spectroscopy ((1)H-MRS) showed an elevated lipid peak and slightly elevated choline/N-acetylaspartate ratio in common. After MTX withdrawal, brain lesions showed spontaneous regression in all cases. Our patient's (1)H-MRS findings and OCBs may reflect a non-monoclonal lymphoproliferative histology as benign-type lesions in CNS-MTX-LPD. The Japanese Society of Internal Medicine 2022-05-21 2022-12-15 /pmc/articles/PMC9841117/ /pubmed/35598995 http://dx.doi.org/10.2169/internalmedicine.9296-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ueno, Hiroki
Ohno, Narumi
Abe, Takafumi
Kimoto, Kazuki
Matsuoka, Chika
Giga, Mayumi
Naito, Hiroyuki
Kono, Tomoyuki
Takasu, Miyuki
Kidani, Naoya
Yamasaki, Rie
Ichimura, Koichi
Nomura, Eiichi
Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
title Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
title_full Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
title_fullStr Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
title_full_unstemmed Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
title_short Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
title_sort prognosis prediction using magnetic resonance spectroscopy and oligoclonal bands in central nervous system methotrexate-associated lymphoproliferative disorder
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841117/
https://www.ncbi.nlm.nih.gov/pubmed/35598995
http://dx.doi.org/10.2169/internalmedicine.9296-21
work_keys_str_mv AT uenohiroki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT ohnonarumi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT abetakafumi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT kimotokazuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT matsuokachika prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT gigamayumi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT naitohiroyuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT konotomoyuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT takasumiyuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT kidaninaoya prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT yamasakirie prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT ichimurakoichi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder
AT nomuraeiichi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder